Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker?

Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker?

BACKGROUND:5-FU based chemotherapy is the most common first line regimen used for metastatic colorectal cancer (mCRC). Identification of predictive markers of response to chemotherapy is a challenging approach for drug selection. The present study analyzes the predictive role of 5-FU degradation rat...

Full description

Bibliographic Details
Main Authors:	Andrea Botticelli, Marina Borro, Concetta Elisa Onesti, Lidia Strigari, Giovanna Gentile, Bruna Cerbelli, Adriana Romiti, Mario Occhipinti, Claudia Sebastiani, Luana Lionetto, Luca Marchetti, Maurizio Simmaco, Paolo Marchetti, Federica Mazzuca
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5033390?pdf=render

Similar Items

Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?
by: Andrea Botticelli, et al.
Published: (2018-08-01)

Combination Therapy of High-Dose Rabeprazole Plus Metronomic Capecitabine in Advanced Gastro-Intestinal Cancer: A Randomized Phase II Trial
by: Michela Roberto, et al.
Published: (2020-10-01)

Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1
by: Andrea Botticelli, et al.
Published: (2020-07-01)

IRINOTECAN, FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan Davidov
Published: (2008-09-01)

A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab
by: Andrea Botticelli, et al.
Published: (2019-03-01)

Drug–Drug Interactions and Pharmacogenomic Evaluation in Colorectal Cancer Patients: The New Drug-PIN<sup>®</sup> System Comprehensive Approach
by: Michela Roberto, et al.
Published: (2021-01-01)

The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon?
by: Michela Roberto, et al.
Published: (2021-08-01)

OXALIPLATIN/5-FLUOROURACIL/LEUCOVORIN IN THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan N. Davidov
Published: (2013-12-01)

Molecular Detection of EMT Markers in Circulating Tumor Cells from Metastatic Non-Small Cell Lung Cancer Patients: Potential Role in Clinical Practice
by: Annalisa Milano, et al.
Published: (2018-01-01)

"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II study
by: Marchetti Paolo, et al.
Published: (2010-10-01)

PD-L1 Expression in TNBC: A Predictive Biomarker of Response to Neoadjuvant Chemotherapy?
by: Bruna Cerbelli, et al.
Published: (2017-01-01)

Anti–PD-1 and Anti–PD-L1 in Head and Neck Cancer: A Network Meta-Analysis
by: Andrea Botticelli, et al.
Published: (2021-08-01)

Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer
by: Silvia Mezi, et al.
Published: (2021-03-01)

Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice
by: Michela Roberto, et al.
Published: (2021-04-01)

BEVACIZUMAB COMBINED WITH IRINOTECAN, 5-FLUOROURACIL AND LEUCOVORIN AS THE FIRST- LINE TREATMENT IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA
by: Deyan Davidov
Published: (2014-12-01)

Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: Relief from immunosuppression is associated with clinical response
by: Botticelli, A., et al.
Published: (2022)

The Role of Soluble LAG3 and Soluble Immune Checkpoints Profile in Advanced Head and Neck Cancer: A Pilot Study
by: Andrea Botticelli, et al.
Published: (2021-07-01)

Low Prostate Concentration of Lycopene Is Associated with Development of Prostate Cancer in Patients with High-Grade Prostatic Intraepithelial Neoplasia
by: Simone Mariani, et al.
Published: (2014-01-01)

Evidence-Based Considerations Exploring Relations between SARS-CoV-2 Pandemic and Air Pollution: Involvement of PM2.5-Mediated Up-Regulation of the Viral Receptor ACE-2
by: Marina Borro, et al.
Published: (2020-08-01)

Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient
by: Edoardo Crimini, et al.
Published: (2019-01-01)

Multiple Chemical Sensitivity Syndrome: A Principal Component Analysis of Symptoms
by: Antonio Del Casale, et al.
Published: (2020-09-01)

Atypical haemolytic-uraemic syndrome in patient with metastatic colorectal cancer treated with fluorouracil and oxaliplatin: a case report and a review of literature
by: Fortunato Ciardiello, et al.
Published: (2019-09-01)

Individualized Drugs’ Selection by Evaluation of Drug Properties, Pharmacogenomics and Clinical Parameters: Performance of a Bioinformatic Tool Compared to a Clinically Established Counselling Process
by: Borro M, et al.
Published: (2021-08-01)

Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions
by: Massimo Ralli, et al.
Published: (2020-01-01)

Evaluation of the efficacy and toxicity of protocol cisplatin, 5-fluorouracil, leucovorin compared to protocol fluorouracil, doxorubicin and mitomycin C in locally advanced and metastatic gastric cancer
by: Andrić Zoran, et al.
Published: (2012-01-01)

Analysis of capecitabine plus oxaliplatin (xelox) combination in the management of metastatic colorectal cancer compare with fluorouracil and oxaliplatin combination (folfox)
by: Isnatin Miladiyah
Published: (2016-12-01)

Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy
by: Vadiaka Maria, et al.
Published: (2002-01-01)

A Synchronous Pancreatic Metastasis from Renal Clear Cell Carcinoma, with Unusual CT Characteristics, Completely Regressed after Therapy with Sunitinib
by: Salvatore Lauro, et al.
Published: (2014-01-01)

Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutation
by: Rossi L, et al.
Published: (2013-11-01)

Lineamentos de análise combinatória /
by: Marchetti, Maurizio.
Published: (2016)

Tissue Immune Profile: A Tool to Predict Response to Neoadjuvant Therapy in Triple Negative Breast Cancer
by: Bruna Cerbelli, et al.
Published: (2020-09-01)

La représentation du personnage de Victoire dans Victoire, les saveurs et les mots de Maryse Condé
by: Marchetti, Federica
Published: (2016)

Att lära sig ordförråd med direktmetoden : Ett experiment med en aktivitet
by: Marchetti, Federica
Published: (2019)

Effect of Gender on Coagulation Functions: A Study in Metastatic Colorectal Cancer Patients Treated with Bevacizumab, Irinotecan, 5-Fluorouracil, and Leucovorin
by: Cemil Bilir, et al.
Published: (2014-01-01)

Mitomycin and 5‐fluorouracil for second‐line treatment of metastatic squamous cell carcinomas of the anal canal
by: Angélique Saint, et al.
Published: (2019-11-01)

An Inhalable Powder Formulation Based on Micro- and Nanoparticles Containing 5-Fluorouracil for the Treatment of Metastatic Melanoma
by: Kelly Cristine Zatta, et al.
Published: (2018-01-01)

Lengua, cultura, identidad
by: Giovanni Gentile G. Marchetti
Published: (2009-11-01)

Antonio Melis: studi letterari e passione civile
by: Giovanni Gentile G. Marchetti
Published: (2016-12-01)

Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer
by: Höhler Thomas, et al.
Published: (2004-07-01)

Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker study
by: Reem D. Mahmood, et al.
Published: (2021-04-01)

Cannot write session to /tmp/vufind_sessions/sess_vd5mo77qe682vnfvbcfthupv2m